Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants
Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.
Materials provided by University of South Australia. Note: Content may be edited for style and length.
Source link aaaaa